+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Deep Brain Stimulation in Parkinson's Disease Market - Global Forecast 2025-2030- Product Image
Deep Brain Stimulation in Parkinson's Disease Market - Global Forecast 2025-2030- Product Image
Sale

Deep Brain Stimulation in Parkinson's Disease Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5532737
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Deep brain stimulation is reshaping Parkinson’s disease therapy, driven by transformative advances in neuromodulation, adaptive technology, and increased clinical adoption. Senior decision-makers require a comprehensive, actionable view of evolving trends, stakeholder strategies, and the shifting regulatory and economic environment to remain competitive in this dynamic sector.

Market Snapshot: Deep Brain Stimulation in Parkinson’s Disease

The Deep Brain Stimulation in Parkinson’s Disease Market grew from USD 1.23 billion in 2024 to USD 1.43 billion in 2025. It is expected to continue growing at a CAGR of 15.51%, reaching USD 2.93 billion by 2030. This trajectory reflects accelerating demand, ongoing product innovation, and a heightened focus on patient-centric neuromodulation solutions. The market landscape is further shaped by global supply chain considerations and competitive pressures, presenting new challenges and opportunities for stakeholders across diagnostics, device manufacturing, and care delivery.

Scope & Segmentation

This report succeeds in capturing pivotal developments and emerging trends shaping deep brain stimulation for Parkinson’s disease. Critical segmentation includes:

  • Technology: Adaptive platforms (such as motion and neural feedback) and conventional neuromodulation systems stand at the forefront of innovation.
  • Component: Analysis covers extensions, implantable pulse generators, leads, and programmers driving modular system flexibility and user efficiency.
  • End User: Adoption dynamics are unique for ambulatory surgical centers, hospitals, and specialty clinics, each contributing to patient pathway optimization and therapy accessibility.
  • Distribution Channel: Direct sales along with distribution partner networks serve as critical levers for market penetration and geographic reach.
  • Regional Coverage: In-depth regional examination spans Americas (with United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (select major markets), and Asia-Pacific (including China, India, Japan, Australia, and more).
  • Company Profiles: Competitive intelligence on major players such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, and innovative emerging firms is included.

Key Takeaways for Decision-Makers

  • Adaptive, closed-loop deep brain stimulation systems are gaining significant traction as the sector prioritizes responsive, patient-specific therapy and expanded indications beyond late-stage disease.
  • Technological progression toward real-time feedback, directional stimulation, and advanced programming is enabling more precise intervention for clinicians while supporting improved patient outcomes.
  • Partnerships between device manufacturers, payers, and healthcare providers are crucial for demonstrating value and influencing reimbursement strategies as market access pathways evolve.
  • Remote monitoring, digital health integration, and machine learning advancements are driving operational innovation, streamlining clinical workflows, and enabling data-driven treatment adaptation.
  • Regional disparities in healthcare infrastructure, reimbursement mechanisms, and regulatory environments underscore the importance of localization and tailored market-entry strategies for effective global scaling.

Tariff Impact on Supply Chains and Cost Structures

Forthcoming United States tariff revisions are expected to influence deep brain stimulation supply chains, with higher duties on key components affecting both sourcing and overall cost structures for manufacturers. These adjustments may drive operational shifts such as nearshoring, vertical integration, and renegotiation of supplier agreements. Companies with diversified production will be better equipped to manage these changes, while emerging market entrants may experience disproportionate cost burdens, intensifying the need for strategic partnerships and advocacy.

Methodology & Data Sources

This analysis leverages a rigorous, multi-source approach. Structured interviews with clinicians, engineers, and reimbursement experts provided direct qualitative insights. Systematic review of scientific literature, regulatory filings, market analytics, and public policy documents were integrated. Quantitative findings were triangulated through company reports and procedure data, with oversight from expert panels to ensure data integrity and reduce bias.

Why This Report Matters for Industry Leaders

  • Uncovers actionable insights into segment drivers, technology adoption, and key market shifts, aligning strategies to the evolving deep brain stimulation landscape.
  • Equips decision-makers to anticipate regulatory and economic risk factors, enabling them to proactively manage supply chain and reimbursement uncertainties.
  • Supports targeted investments in adaptive technology, regional market entry, and stakeholder collaboration critical for long-term value creation.

Conclusion

As deep brain stimulation in Parkinson’s disease enters a period of rapid evolution, organizations must integrate innovation, operational agility, and local adaptation into their strategies. Robust research, tailored initiatives, and collaborative stakeholder partnerships will be pivotal for those aiming to lead in this complex market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of closed-loop adaptive stimulation systems with real-time neural feedback
5.2. Expansion of directional lead technology for more precise targeting and symptom control
5.3. Integration of AI-driven programming algorithms to optimize patient-specific stimulation parameters
5.4. Development of minimally invasive stereotactic approaches with improved surgical accuracy
5.5. Growing adoption of rechargeable implantable pulse generators to reduce replacement surgeries
5.6. Advances in wireless telemetry for remote DBS device monitoring and noninvasive parameter adjustment
5.7. Increasing emphasis on personalized therapy protocols based on patient phenotype and biomarker profiles
5.8. Collaboration between neurotechnology companies and academic institutions for next-generation DBS research
5.9. Rising investments in disease-modifying neuromodulation paradigms targeting non-motor symptom relief
5.10. Regulatory approvals of novel electrode designs enabling multi-contact current steering capabilities
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Deep Brain Stimulation in Parkinson’s Disease Market, by Technology
8.1. Introduction
8.2. Adaptive
8.2.1. Motion Feedback
8.2.2. Neural Feedback
8.3. Conventional
9. Deep Brain Stimulation in Parkinson’s Disease Market, by Component
9.1. Introduction
9.2. Extension
9.3. Implantable Pulse Generator
9.4. Lead
9.5. Programmer
10. Deep Brain Stimulation in Parkinson’s Disease Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Deep Brain Stimulation in Parkinson’s Disease Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distribution Partner Networks
12. Americas Deep Brain Stimulation in Parkinson’s Disease Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Boston Scientific Corporation
15.3.3. Abbott Laboratories
15.3.4. Neurology Solutions
15.3.5. Suzhou PINS Medical Co., Ltd.
15.3.6. Aleva Neurotherapeutics SA
15.3.7. Renishaw plc
15.3.8. Newronika S.r.l.
15.3.9. LivaNova, plc
15.3.10. Inomed Medizintechnik GmbH
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET: RESEARCHAI
FIGURE 24. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET: RESEARCHSTATISTICS
FIGURE 25. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET: RESEARCHCONTACTS
FIGURE 26. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY MOTION FEEDBACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY MOTION FEEDBACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY NEURAL FEEDBACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY NEURAL FEEDBACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY CONVENTIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY EXTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY EXTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY IMPLANTABLE PULSE GENERATOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY IMPLANTABLE PULSE GENERATOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY LEAD, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY LEAD, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PROGRAMMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PROGRAMMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION PARTNER NETWORKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION PARTNER NETWORKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 69. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 70. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 71. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 72. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 73. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 74. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 75. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. CANADA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 80. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 81. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 82. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 83. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 84. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 85. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. MEXICO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 134. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 135. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 136. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 137. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. GERMANY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 144. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 145. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 146. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 147. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. FRANCE DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 164. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 165. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 166. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 167. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. ITALY DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 174. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 175. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 176. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 177. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. SPAIN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 214. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 215. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 216. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 217. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. DENMARK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 234. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 235. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 236. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 237. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. QATAR DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 244. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 245. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 246. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 247. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. FINLAND DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY ADAPTIVE, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. EGYPT DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. EGYPT DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. EGYPT DEEP BRAIN ST

Samples

Loading
LOADING...

Companies Mentioned

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Neurology Solutions
  • Suzhou PINS Medical Co., Ltd.
  • Aleva Neurotherapeutics SA
  • Renishaw plc
  • Newronika S.r.l.
  • LivaNova, plc
  • Inomed Medizintechnik GmbH

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.93 Billion
Compound Annual Growth Rate15.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report By Product (Single-channel, Dual-channel), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report By Product (Single-channel, Dual-channel), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Deep Brain Stimulation in Parkinson's Disease - Global Strategic Business Report - Product Image

Deep Brain Stimulation in Parkinson's Disease - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Deep Brain Stimulation Market Report by Stimulation Type, Product, Application, End-User, and Region 2025-2033 - Product Image

Deep Brain Stimulation Market Report by Stimulation Type, Product, Application, End-User, and Region 2025-2033

  • Report
  • 142 Pages
  • Global
From
Deep Brain Stimulation Devices Market - A Global and Regional Analysis: Focus on Product, Application, End User, and Region - Analysis and Forecast, 2025-2035 - Product Image

Deep Brain Stimulation Devices Market - A Global and Regional Analysis: Focus on Product, Application, End User, and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From

About the Deep Brain Stimulation In Parkinson Disease Market

Deep brain stimulation (DBS) for Parkinson's disease is a therapeutic procedure aimed at managing the symptoms of this neurodegenerative disorder when medication is insufficient or leads to undesirable side effects. This method involves the surgical implantation of electrodes within certain areas of the brain, generating electrical impulses that regulate abnormal impulses. The DBS devices are an integral part of the Central Nervous System (CNS) drugs and devices domain, which encompasses a broad range of therapies for various neurological conditions, including medication, neuromodulation devices, and support services. Within this context, DBS acts as an adjunct to pharmacological treatments, offering an alternative for patients with advanced Parkinson's disease. While CNS drugs typically address the dopaminergic deficits inherent to Parkinson's disease pathophysiology through oral or injectable medications, DBS provides a unique mechanistic approach by directly modulating brain activity and circuits involved in motor control. The procedure is generally reserved for patients exhibiting motor fluctuations and tremors that are not adequately controlled by medication. Several industry players are active in the DBS market for Parkinson's disease. Key companies engaged in the development and provision of DBS systems include Medtronic, Boston Scientific, and Abbott Laboratories. These entities continuously engage in research and development to advance the technology, increase its efficacy, and reduce any associated risks, thereby improving the lives of patients with Parkinson's disease. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.